Company news

Vogenx Inc news

Latest news releases, newest first.

View company

Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia

October 15, 2026

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

October 9, 2026

Vogenx Announces Closing of Initial Public Offering

August 13, 2026

Decks